Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-02-25 @ 7:02 PM
Study NCT ID:
NCT01641133
Status:
COMPLETED
Last Update Posted:
2021-03-02
First Post:
2012-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09-04
Start Date Type:
ACTUAL
Primary Completion Date:
2013-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-12
First Submit QC Date:
None
Study First Post Date:
2012-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-09
Results First Submit QC Date:
None
Results First Post Date:
2017-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-08-30
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-02-08
Last Update Post Date:
2021-03-02
Last Update Post Date Type:
ACTUAL